Genomic Characteristics of MPNs in IR-Exposed Patients
Demographics (3)
- AGE - Subject age at DNA sampling (phv00407187.v1.p1)
- AGE_IR_EXPOSURE - Age at time of IR-exposure (phv00407189.v1.p1)
- SEX - Self-reported sex (phv00407185.v1.p1)
Disease Events (7)
- AFFECTION_STATUS - Presence or absence of myeloproliferative neoplasm (MPN) (phv00407190.v1.p1)
- AGE_ONSET - Disease onset age (phv00407188.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00407195.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00407197.v1.p1)
- IS_TUMOR - Tumor status (phv00407196.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00407199.v1.p1)
- SUBTYPE_MPN - Subtype of MPN (Polycytemia Vera (PV), Essential Thrombocythemia (ET), or Primary Myelofibrosis (PMF) (phv00407184.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00407186.v1.p1)
Other (11)
- BODY_SITE - Body site where sample was collected (phv00407194.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00407180.v1.p1)
- IR_EXPOSURE - Exposure to Ionizing Radiation (phv00407191.v1.p1)
- POOLED_SAMPLE - Pooled sample of 89 healthy controls, IR-unexposed (phv00407192.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00407198.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00407193.v1.p1)
- SAMPLE_ID - Sample ID (phv00407182.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00407200.v1.p1)
- SUBJECT_ID - Subject ID (phv00407183.v1.p1)
- SUBJECT_ID - Subject ID (phv00407179.v1.p1)
- SUBJECT_ID - Subject ID (phv00407181.v1.p1)